Evidence map›Paper›PMID 29176567›Full record

ArticleNature communications2017

Plasma cell survival in the absence of B cell memory.

Erika Hammarlund, Archana Thomas, Ian J Amanna, Lindsay A Holden, Ov D Slayden, Byung Park, Lina Gao, Mark K Slifka

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 201 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Why are long-lived plasma cells long-lived?Frontiers in immunology · 2026
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Distinct autoreactive CD19Nature communications · 2025
    Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Erika HammarlundDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006, USA.
Archana ThomasDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006, USA.
Ian J AmannaNajít Technologies, Inc, 505 NW 185th Avenue, Beaverton, OR, 97006, USA.
Lindsay A HoldenDepartment of Biology, Portland State University, 1719 SW 10th Avenue, Portland, OR, 97201, USA.ORCID http://orcid.org/0000-0002-3759-9497
Ov D SlaydenDivision of Reproductive Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006, USA.
Byung ParkBiostatistics Shared Resource, Knight Cancer Institute, 3181 SW Sam Jackson Park Rd., Portland, OR, 97239, USA.
Lina GaoBiostatistics Shared Resource, Knight Cancer Institute, 3181 SW Sam Jackson Park Rd., Portland, OR, 97239, USA.
Mark K SlifkaDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Avenue, Beaverton, OR, 97006, USA. slifkam@ohsu.edu.
Oregon National Primate Research Center · USOHSU Knight Cancer InstituteNajít Technologies (United States) · USPortland State University · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Vaccination and immune senescence in primatesP01AG023664 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIKOLICH, JANKO Z. · 2004 to 2008
$9.7M
Development of a Safe and Effective Vaccine Against West Nile VirusU01AI082196 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI SLIFKA, MARK K · 2009 to 2012
$7.1M
NIAID NIH HHS U01 AI082196NIA NIH HHS P01 AG023664NIH HHS P51 OD011092
6 · The paper itself

Abstract

Pre-existing serum antibodies play an important role in vaccine-mediated protection against infection but the underlying mechanisms of immune memory are unclear. Clinical studies indicate that antigen-specific antibody responses can be maintained for many years, leading to theories that reactivation/differentiation of memory B cells into plasma cells is required to sustain long-term antibody production. Here, we present a decade-long study in which we demonstrate site-specific survival of bone marrow-derived plasma cells and durable antibody responses to multiple virus and vaccine antigens in rhesus macaques for years after sustained memory B cell depletion. Moreover, BrdU

Indexed as

Immunologic MemoryAnimalsAntibodies, BacterialAntibody FormationBacterial VaccinesB-LymphocytesCell SurvivalMacaca mulattaMalePlasma CellsVaccinationAntibodies, BacterialBacterial Vaccines

Identifiers

PMID29176567
PMCPMC5701209
OpenAlexW2770797413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.